{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T10:40:09Z","timestamp":1750502409348,"version":"3.41.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,21]]},"DOI":"10.7759\/cureus.86477","type":"journal-article","created":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T09:58:21Z","timestamp":1750499901000},"source":"Crossref","is-referenced-by-count":0,"title":["Evaluating the Use of Amoxicillin in Community-Acquired Pneumonia Patients With Low Confusion, Urea, Respiratory Rate, Blood Pressure, and Age \u226565 Years (CURB-65) Scores: A Retrospective Study"],"prefix":"10.7759","author":[{"given":"Trimanjot Singh","family":"Anand","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wilsonne Andrew Kyle T","family":"Chua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soo Hyun","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Cristea-Nicoara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2009.121434","article-title":"BTS guidelines for the management of community acquired pneumonia in adults: update 2009","volume":"64 Suppl 3","author":"Lim WS","year":"2009","unstructured":"Lim WS, Baudouin SV, George RC, et al.. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax. 2009, 64 Suppl 3:iii1-55. 10.1136\/thx.2009.121434","journal-title":"Thorax"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201908-1581ST","article-title":"Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America","volume":"200","author":"Metlay JP","year":"2019","unstructured":"Metlay JP, Waterer GW, Long AC, et al.. Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med. 2019, 200:e45-67. 10.1164\/rccm.201908-1581ST","journal-title":"Am J Respir Crit Care Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/thorax.58.5.377","article-title":"Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study","volume":"58","author":"Lim WS","year":"2003","unstructured":"Lim WS, van der Eerden MM, Laing R, et al.. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax. 2003, 58:377-82. 10.1136\/thorax.58.5.377","journal-title":"Thorax"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2016.04.008","article-title":"Risk factors for Clostridium difficile infection in hospitalized patients with community-acquired pneumonia","volume":"73","author":"Chalmers JD","year":"2016","unstructured":"Chalmers JD, Akram AR, Singanayagam A, Wilcox MH, Hill AT. Risk factors for Clostridium difficile infection in hospitalized patients with community-acquired pneumonia. J Infect. 2016, 73:45-53. 10.1016\/j.jinf.2016.04.008","journal-title":"J Infect"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa124","article-title":"Antibiotic prescribing choices and their comparative C. difficile infection risk: a longitudinal case-cohort study","volume":"72","author":"Brown KA","year":"2021","unstructured":"Brown KA, Langford B, Schwartz KL, Diong C, Garber G, Daneman N. Antibiotic prescribing choices and their comparative C. difficile infection risk: a longitudinal case-cohort study. Clin Infect Dis. 2021, 72:836-44. 10.1093\/cid\/ciaa124","journal-title":"Clin Infect Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1086\/511159","article-title":"Infectious Diseases Society of America\/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults","volume":"44 Suppl 2","author":"Mandell LA","year":"2007","unstructured":"Mandell LA, Wunderink RG, Anzueto A, et al.. Infectious Diseases Society of America\/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007, 44 Suppl 2:S27-72. 10.1086\/511159","journal-title":"Clin Infect Dis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3904\/kjim.2023.558","article-title":"Role of biomarkers in antimicrobial stewardship: physicians' perspectives","volume":"39","author":"Seok H","year":"2024","unstructured":"Seok H, Park DW. Role of biomarkers in antimicrobial stewardship: physicians' perspectives. Korean J Intern Med. 2024, 39:413-29. 10.3904\/kjim.2023.558","journal-title":"Korean J Intern Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkt212","article-title":"Declining cephalosporin and fluoroquinolone non-susceptibility among bloodstream Enterobacteriaceae from the UK: links to prescribing change?","volume":"68","author":"Livermore DM","year":"2013","unstructured":"Livermore DM, Hope R, Reynolds R, Blackburn R, Johnson AP, Woodford N. Declining cephalosporin and fluoroquinolone non-susceptibility among bloodstream Enterobacteriaceae from the UK: links to prescribing change?. J Antimicrob Chemother. 2013, 68:2667-74. 10.1093\/jac\/dkt212","journal-title":"J Antimicrob Chemother"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/phar.1636","article-title":"Infections caused by resistant Gram-negative bacteria: epidemiology and management","volume":"35","author":"Kaye KS","year":"2015","unstructured":"Kaye KS, Pogue JM. Infections caused by resistant Gram-negative bacteria: epidemiology and management. Pharmacotherapy. 2015, 35:949-62. 10.1002\/phar.1636","journal-title":"Pharmacotherapy"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1166742","article-title":"Guidance on C-reactive protein point-of-care testing and complementary strategies to improve antibiotic prescribing for adults with lower respiratory tract infections in primary care","volume":"10","author":"Van Hecke O","year":"2023","unstructured":"Van Hecke O, Bjerrum L, Gentile I, et al.. Guidance on C-reactive protein point-of-care testing and complementary strategies to improve antibiotic prescribing for adults with lower respiratory tract infections in primary care. Front Med (Lausanne). 2023, 10:1166742. 10.3389\/fmed.2023.1166742","journal-title":"Front Med (Lausanne)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.0852","article-title":"Procalcitonin testing to guide antibiotic therapy in acute upper and lower respiratory tract infections","volume":"319","author":"Schuetz P","year":"2018","unstructured":"Schuetz P, Wirz Y, Mueller B. Procalcitonin testing to guide antibiotic therapy in acute upper and lower respiratory tract infections. JAMA. 2018, 319:925-6. 10.1001\/jama.2018.0852","journal-title":"JAMA"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)15591-8","article-title":"Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial","volume":"363","author":"Christ-Crain M","year":"2004","unstructured":"Christ-Crain M, Jaccard-Stolz D, Bingisser R, Gencay MM, Huber PR, Tamm M, M\u00fcller B. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet. 2004, 363:600-7. 10.1016\/S0140-6736(04)15591-8","journal-title":"Lancet"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2009.1297","article-title":"Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial","volume":"302","author":"Schuetz P","year":"2009","unstructured":"Schuetz P, Christ-Crain M, Thomann R, et al.. Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial. JAMA. 2009, 302:1059-66. 10.1001\/jama.2009.1297","journal-title":"JAMA"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010130.pub2","article-title":"Biomarkers as point-of-care tests to guide prescription of antibiotics in patients with acute respiratory infections in primary care","author":"Aabenhus R","year":"2014","unstructured":"Aabenhus R, Jensen JU, J\u00f8rgensen KJ, Hr\u00f3bjartsson A, Bjerrum L. Biomarkers as point-of-care tests to guide prescription of antibiotics in patients with acute respiratory infections in primary care. Cochrane Database Syst Rev. 2014, CD010130. 10.1002\/14651858.CD010130.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1186\/cc4955","article-title":"Pro-adrenomedullin to predict severity and outcome in community-acquired pneumonia [ISRCTN04176397]","volume":"10","author":"Christ-Crain M","year":"2006","unstructured":"Christ-Crain M, Morgenthaler NG, Stolz D, et al.. Pro-adrenomedullin to predict severity and outcome in community-acquired pneumonia [ISRCTN04176397]. Crit Care. 2006, 10:R96. 10.1186\/cc4955","journal-title":"Crit Care"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1086\/589754","article-title":"SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia","volume":"47","author":"Charles PG","year":"2008","unstructured":"Charles PG, Wolfe R, Whitby M, et al.. SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia. Clin Infect Dis. 2008, 47:375-84. 10.1086\/589754","journal-title":"Clin Infect Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/375093-evaluating-the-use-of-amoxicillin-in-community-acquired-pneumonia-patients-with-low-confusion-urea-respiratory-rate-blood-pressure-and-age-65-years-curb-65-scores-a-retrospective-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T09:58:21Z","timestamp":1750499901000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/375093-evaluating-the-use-of-amoxicillin-in-community-acquired-pneumonia-patients-with-low-confusion-urea-respiratory-rate-blood-pressure-and-age-65-years-curb-65-scores-a-retrospective-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,21]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.86477","relation":{},"ISSN":["2168-8184"],"issn-type":[{"type":"print","value":"2168-8184"}],"subject":[],"published":{"date-parts":[[2025,6,21]]}}}